141 related articles for article (PubMed ID: 29100291)
1. Hinokitiol up-regulates miR-494-3p to suppress BMI1 expression and inhibits self-renewal of breast cancer stem/progenitor cells.
Chen SM; Wang BY; Lee CH; Lee HT; Li JJ; Hong GC; Hung YC; Chien PJ; Chang CY; Hsu LS; Chang WW
Oncotarget; 2017 Sep; 8(44):76057-76068. PubMed ID: 29100291
[TBL] [Abstract][Full Text] [Related]
2. Hinokitiol inhibits vasculogenic mimicry activity of breast cancer stem/progenitor cells through proteasome-mediated degradation of epidermal growth factor receptor.
Tu DG; Yu Y; Lee CH; Kuo YL; Lu YC; Tu CW; Chang WW
Oncol Lett; 2016 Apr; 11(4):2934-2940. PubMed ID: 27073579
[TBL] [Abstract][Full Text] [Related]
3. Differential expression of miR-200c in breast cancer stem cells.
Wu D; Ji N; Zhang L; Zhang L
Int J Clin Exp Pathol; 2017; 10(9):10085-10091. PubMed ID: 31966899
[TBL] [Abstract][Full Text] [Related]
4. Down regulation of miR200c promotes radiation-induced thymic lymphoma by targeting BMI1.
Cui J; Cheng Y; Zhang P; Sun M; Gao F; Liu C; Cai J
J Cell Biochem; 2014 Jun; 115(6):1033-42. PubMed ID: 24375660
[TBL] [Abstract][Full Text] [Related]
5. miR-376c-3p modulates the properties of breast cancer stem cells by targeting RAB2A.
Zhao F; Zhong M; Pei W; Tian B; Cai Y
Exp Ther Med; 2020 Nov; 20(5):68. PubMed ID: 32963598
[TBL] [Abstract][Full Text] [Related]
6. Essential role of miR-200c in regulating self-renewal of breast cancer stem cells and their counterparts of mammary epithelium.
Feng ZM; Qiu J; Chen XW; Liao RX; Liao XY; Zhang LP; Chen X; Li Y; Chen ZT; Sun JG
BMC Cancer; 2015 Sep; 15():645. PubMed ID: 26400441
[TBL] [Abstract][Full Text] [Related]
7. Hinokitiol Inhibits Breast Cancer Cells In Vitro Stemness-Progression and Self-Renewal with Apoptosis and Autophagy Modulation via the CD44/Nanog/SOX2/Oct4 Pathway.
Chiang YF; Huang KC; Chen HY; Hamdy NM; Huang TC; Chang HY; Shieh TM; Huang YJ; Hsia SM
Int J Mol Sci; 2024 Mar; 25(7):. PubMed ID: 38612715
[TBL] [Abstract][Full Text] [Related]
8. miR-15a/miR-16 induces mitochondrial dependent apoptosis in breast cancer cells by suppressing oncogene BMI1.
Patel N; Garikapati KR; Ramaiah MJ; Polavarapu KK; Bhadra U; Bhadra MP
Life Sci; 2016 Nov; 164():60-70. PubMed ID: 27596816
[TBL] [Abstract][Full Text] [Related]
9. Enhanced SLC34A2 in breast cancer stem cell-like cells induces chemotherapeutic resistance to doxorubicin via SLC34A2-Bmi1-ABCC5 signaling.
Ge G; Zhou C; Ren Y; Tang X; Wang K; Zhang W; Niu L; Zhou Y; Yan Y; He J
Tumour Biol; 2016 Apr; 37(4):5049-62. PubMed ID: 26546432
[TBL] [Abstract][Full Text] [Related]
10. miR-27b-3p suppresses cell proliferation through targeting receptor tyrosine kinase like orphan receptor 1 in gastric cancer.
Tao J; Zhi X; Zhang X; Fu M; Huang H; Fan Y; Guan W; Zou C
J Exp Clin Cancer Res; 2015 Nov; 34():139. PubMed ID: 26576539
[TBL] [Abstract][Full Text] [Related]
11. Hinokitiol suppresses cancer stemness and oncogenicity in glioma stem cells by Nrf2 regulation.
Ouyang WC; Liao YW; Chen PN; Lu KH; Yu CC; Hsieh PL
Cancer Chemother Pharmacol; 2017 Aug; 80(2):411-419. PubMed ID: 28685346
[TBL] [Abstract][Full Text] [Related]
12. Downregulation of microRNA-362-3p and microRNA-329 promotes tumor progression in human breast cancer.
Kang H; Kim C; Lee H; Rho JG; Seo JW; Nam JW; Song WK; Nam SW; Kim W; Lee EK
Cell Death Differ; 2016 Mar; 23(3):484-95. PubMed ID: 26337669
[TBL] [Abstract][Full Text] [Related]
13. MicroRNA-331-3p Suppresses Cervical Cancer Cell Proliferation and E6/E7 Expression by Targeting NRP2.
Fujii T; Shimada K; Asano A; Tatsumi Y; Yamaguchi N; Yamazaki M; Konishi N
Int J Mol Sci; 2016 Aug; 17(8):. PubMed ID: 27548144
[TBL] [Abstract][Full Text] [Related]
14. miR-494-3p Induces Cellular Senescence and Enhances Radiosensitivity in Human Oral Squamous Carcinoma Cells.
Weng JH; Yu CC; Lee YC; Lin CW; Chang WW; Kuo YL
Int J Mol Sci; 2016 Jul; 17(7):. PubMed ID: 27399693
[TBL] [Abstract][Full Text] [Related]
15. Dysregulation of the miR-34a-SIRT1 axis inhibits breast cancer stemness.
Ma W; Xiao GG; Mao J; Lu Y; Song B; Wang L; Fan S; Fan P; Hou Z; Li J; Yu X; Wang B; Wang H; Wang H; Xu F; Li Y; Liu Q; Li L
Oncotarget; 2015 Apr; 6(12):10432-44. PubMed ID: 25826085
[TBL] [Abstract][Full Text] [Related]
16. Ovatodiolide Inhibits Breast Cancer Stem/Progenitor Cells through SMURF2-Mediated Downregulation of Hsp27.
Lu KT; Wang BY; Chi WY; Chang-Chien J; Yang JJ; Lee HT; Tzeng YM; Chang WW
Toxins (Basel); 2016 Apr; 8(5):. PubMed ID: 27136586
[TBL] [Abstract][Full Text] [Related]
17. MicroRNA-409-3p regulates cell invasion and metastasis by targeting ZEB1 in breast cancer.
Ma Z; Li Y; Xu J; Ren Q; Yao J; Tian X
IUBMB Life; 2016 May; 68(5):394-402. PubMed ID: 27079864
[TBL] [Abstract][Full Text] [Related]
18. MicroRNA-139-5p inhibits bladder cancer proliferation and self-renewal by targeting the Bmi1 oncogene.
Luo H; Yang R; Li C; Tong Y; Fan L; Liu X; Xu C
Tumour Biol; 2017 Jul; 39(7):1010428317718414. PubMed ID: 28720065
[TBL] [Abstract][Full Text] [Related]
19. MiR-142-3p represses TGF-β-induced growth inhibition through repression of TGFβR1 in non-small cell lung cancer.
Lei Z; Xu G; Wang L; Yang H; Liu X; Zhao J; Zhang HT
FASEB J; 2014 Jun; 28(6):2696-704. PubMed ID: 24558198
[TBL] [Abstract][Full Text] [Related]
20. Increased fucosylation has a pivotal role in multidrug resistance of breast cancer cells through miR-224-3p targeting FUT4.
Feng X; Zhao L; Gao S; Song X; Dong W; Zhao Y; Zhou H; Cheng L; Miao X; Jia L
Gene; 2016 Mar; 578(2):232-41. PubMed ID: 26701615
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]